In April 2015, the Consensus Standards Approval Committee (CSAC) agreed to make approval for trial use available for all eMeasures submitted to NQF. Approval for trial use is NOT time-limited endorsement as it carries no endorsement label. Furthermore, although the Trial Use Program is a pathway for measures to be potentially be considered for endorsement, it is not a mechanism by which measures should be considered that do not comply with NQF’s criteria regarding Important to Measure and Report, nor ones in which data to evaluate its Scientific Acceptability cannot reasonably be collected within an electronic health record. Measures approved for trial use will be so indicated on QPS. See Table 12 (PDF) for comparison of endorsement and approval for trial use.
eMeasure candidates for the Trial Use Program are initially screened by the eMeasure and Maintenance Measure Review team. Criteria for approval for Trial Use include:
Candidacy for approval for Trial Use are reviewed much like any eMeasure by the standing committee in a project, based on the standard NQF criteria. The main difference between Approval for Trial Use and standard endorsement is that the completion of measure testing is not needed prior to committee review to receive Approval for Trial Use status.
1030 15th Street NWSuite 800Washington DC 20005
202-783-1300 Main202-783-3434 Faxinfo@qualityforum.org